Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins
Product Description
Canton Biologics
-
Country/Region:Hong Kong
-
Founded:2016
-
On CPHI since:2026
-
Employees:250 - 499
Company types
Categories
Specifications
Canton Biologics
-
Country/Region:Hong Kong
-
Founded:2016
-
On CPHI since:2026
-
Employees:250 - 499
Company types
More Products from Canton Biologics (2)
-
Product Biologics Development Solutions for Companion Animal Therapeutics
Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.
-
Product Biomedical and Healthcare Recombinant Protein Solutions
Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...

